Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | AZN | AMGN | GILD | BMY |
| Company | Blueprint Medicines Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 129.35 | 207.30 | 357.46 | 142.38 | 59.79 |
| High | 129.55 | 207.30 | 357.46 | 142.38 | 59.80 |
| Low | 129.30 | 204.27 | 351.24 | 139.62 | 58.61 |
| Latest | 129.46 | 204.29 | 352.61 | 139.56 | 58.66 |
| Change | +0.18 | -0.70 | -2.99 | -2.53 | -0.81 |
| % Change | +0.14% | -0.34% | -0.84% | -1.78% | -1.36% |
| Volume | 2,980,900 | 852,743 | 688,964 | 1,375,177 | 3,168,199 |
| 20-Day Average Volume | 4,470,280 | 1,828,825 | 2,663,365 | 5,749,627 | 13,107,633 |
| Previous Close | 129.28 | 204.99 | 355.60 | 142.09 | 59.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 193.78 | 351.96 | 139.86 | 59.05 |
| 20-Day Raw Stochastic | 88.49% | 88.34% | 45.52% | 41.45% | 42.42% |
| 20-Day Relative Strength | 73.17 | 59.67 | 47.78 | 48.18 | 49.58 |
| Weighted Alpha | +17.08 | +53.46 | +24.07 | +34.29 | +22.48 |
| Today's Opinion | 100% Buy | 88% Buy | 56% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 56% Buy | 56% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 64% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +0.44% since 04/02/26 | +1.26% since 04/02/26 | +0.09% since 04/02/26 | -1.17% since 04/02/26 |
| Low | 129.00 on 07/11/25 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 129.65 on 07/16/25 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.79 on 04/10/26 |
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | +4.82% since 03/10/26 | -6.16% since 03/10/26 | -5.88% since 03/10/26 | -2.05% since 03/10/26 |
| Low | 128.00 on 06/20/25 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 129.65 on 07/16/25 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +7.97% since 01/09/26 | +8.04% since 01/09/26 | +15.47% since 01/09/26 | +5.44% since 01/09/26 |
| Low | 83.27 on 04/22/25 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 129.65 on 07/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +20.90% since 10/10/25 | +21.44% since 10/10/25 | +19.33% since 10/10/25 | +33.99% since 10/10/25 |
| Low | 73.04 on 04/09/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 129.65 on 07/16/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 317,920,640 | 191,911,984 | 176,365,248 | 121,421,984 |
| Shares Outstanding, K | 64,582 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 508,820,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -67,090,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 149,410,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 500,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.89 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 08/07/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.30 | 16.01 | 17.37 | 9.63 |